It is important to know that you are not alone on your treatment journey. Numerous resources are available free and online to cancer patients and their caregivers.
These resources can help you learn more about the science of cancer immunotherapy and other advances in cancer treatment, where to seek financial help, and how to connect with other patient support and advocacy groups.
Read our primer on the immune system and how scientists are unlocking its power to fight and ultimately cure all types of cancer.
An eight-step guide for cancer patients on how to get the best care followed by an information section and resource directory
Organizations that provide support and reliable answers for cancer patients and their loved ones
A comprehensive glossary that will help explain some of the terms you'll come across on our website
Expert scientists and physicians answer common patient questions.
About Immunotherapy Clinical Trials
About Immunotherapy 101
About Immunotherapy and the Brain
Tools and resources you can print and take with you.
Patients provide a vital perspective on the experience of cancer diagnosis, the consideration of treatment options, side effects, immunotherapy, and clinical trials. Review a collection of patient responses from our Immunocommunity for a greater understanding of each individual's experience.
How and when did you first learn you had cancer?
How did you learn about immunotherapy and why did you decide to do it?
What was treatment like? Did you have any side effects?
How did immunotherapy compare to other treatments you may have received, if any?
Are there things that surprise you about the cancer experience?
What would you want another patient to know about immunotherapy or about participating in a clinical trial?
Join the conversation and share your story with the Immunocommunity.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and others’ efforts to overcome resistance to PD-1 therapy as well as insights into the role of dendritic cells.
Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors governing immunotherapy’s effectiveness in several other cancer types